Halozyme Therapeutics Correlations

HALO Stock

USD 59.26 0.02 0.03%

The current 90-days correlation between Halozyme Therapeutics and Insmed Inc is 0.14 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Halozyme Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Halozyme Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Halozyme Therapeutics Correlation With Market

Very weak diversification

The correlation between Halozyme Therapeutics and DJI is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Halozyme Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.

Moving together with Halozyme Stock

0.77	A	Agilent Technologies Sell-off Trend	Pair Corr
0.77	EQ	Equillium	Pair Corr
0.85	DMAC	DiaMedica Therapeutics	Pair Corr
0.82	DNLI	Denali Therapeutics	Pair Corr
0.89	VCYT	Veracyte	Pair Corr
0.73	DSGN	Design Therapeutics Upward Rally	Pair Corr
0.86	EXAS	EXACT Sciences	Pair Corr
0.81	BMY	Bristol Myers Squibb	Pair Corr
0.86	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.67	TMO	Thermo Fisher Scientific	Pair Corr
0.79	WAT	Waters	Pair Corr
0.82	GILD	Gilead Sciences	Pair Corr
0.92	ILMN	Illumina	Pair Corr

Moving against Halozyme Stock

0.74	DOMH	Dominari Holdings	Pair Corr
0.7	DRMA	Dermata Therapeutics	Pair Corr
0.52	CDIOW	Cardio Diagnostics	Pair Corr
0.5	VCNX	Vaccinex	Pair Corr
0.31	SABSW	SAB Biotherapeutics	Pair Corr
0.83	HRTX	Heron Therapeuti	Pair Corr
0.83	IXHL	Incannex Healthcare	Pair Corr
0.77	EVOK	Evoke Pharma	Pair Corr
0.67	MRK	Merck Company Sell-off Trend	Pair Corr
0.64	HOOK	Hookipa Pharma	Pair Corr
0.53	NAMSW	NewAmsterdam Pharma	Pair Corr
0.38	XFOR	X4 Pharmaceuticals	Pair Corr

Related Correlations Analysis

	AGIO	INSM	CERE	RARE	BMRN	SGEN	ALNY	EXEL	ALEC	LEGN
AGIO		0.2	0.1	0.1	0.14	0.0	-0.16	-0.04	0.62	0.45	AGIO
INSM	0.2		-0.03	0.6	0.62	-0.79	0.8	0.57	0.65	0.81	INSM
CERE	0.1	-0.03		-0.18	0.11	0.11	-0.1	-0.17	-0.16	0.03	CERE
RARE	0.1	0.6	-0.18		0.76	-0.42	0.64	0.89	0.22	0.66	RARE
BMRN	0.14	0.62	0.11	0.76		-0.34	0.51	0.81	0.15	0.58	BMRN
SGEN	0.0	-0.79	0.11	-0.42	-0.34		-0.68	-0.34	-0.47	-0.53	SGEN
ALNY	-0.16	0.8	-0.1	0.64	0.51	-0.68		0.65	0.34	0.66	ALNY
EXEL	-0.04	0.57	-0.17	0.89	0.81	-0.34	0.65		0.14	0.62	EXEL
ALEC	0.62	0.65	-0.16	0.22	0.15	-0.47	0.34	0.14		0.74	ALEC
LEGN	0.45	0.81	0.03	0.66	0.58	-0.53	0.66	0.62	0.74		LEGN
	AGIO	INSM	CERE	RARE	BMRN	SGEN	ALNY	EXEL	ALEC	LEGN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EXEL	+ 0.89	RARE
LEGN	+ 0.81	INSM
EXEL	+ 0.81	BMRN
ALNY	+ 0.8	INSM
BMRN	+ 0.76	RARE
LEGN	+ 0.74	ALEC

High negative correlations

SGEN	- 0.79	INSM
ALNY	- 0.68	SGEN
LEGN	- 0.53	SGEN
ALEC	- 0.47	SGEN
SGEN	- 0.42	RARE
EXEL	- 0.34	SGEN

Risk-Adjusted Indicators

There is a big difference between Halozyme Stock performing well and Halozyme Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Halozyme Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AGIO	1.74	(0.16)	0.00	(0.08)	0.00	0.00	3.67	(3.45)	10.62
INSM	1.98	0.33	0.14	0.56	1.86	(2.19)	5.07	(3.88)	17.58
CERE	0.77	0.09	0.01	(0.41)	0.94	(1.02)	1.91	(1.59)	6.40
RARE	1.98	0.45	0.16	1.57	2.34	(2.33)	4.49	(3.05)	17.26
BMRN	1.20	0.03	0.01	0.10	1.60	(1.29)	2.20	(2.05)	13.23
SGEN	0.58	(0.06)	0.00	0.45	0.00	0.00	1.02	(0.89)	6.86
ALNY	2.40	0.91	0.37	8.81	1.66	(2.97)	5.27	(2.59)	42.99
EXEL	1.09	0.25	0.21	1.13	0.67	(1.40)	2.73	(1.50)	15.18
ALEC	3.37	0.36	0.11	0.22	3.34	(4.34)	8.66	(5.07)	19.87
LEGN	2.11	0.07	0.02	0.14	2.80	(2.19)	4.29	(4.28)	22.76

Halozyme Therapeutics Corporate Management

Mark Esq	Senior Officer	Profile
Kristin Schwartzbauer	Head Quality	Profile
Gary Grote	Chief Officer	Profile
Nicole LaBrosse	CFO Director	Profile
MD MBA	Chief Officer	Profile
Amy Fox	Senior Resources	Profile
Cortney MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC